We are live on ! Find out more
CGEM icon

Cullinan Oncology
CGEM

66 hedge funds and large institutions have $762M invested in Cullinan Oncology in 2021 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 33 increasing their positions, 11 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 11

3.67% more ownership

Funds ownership: 74.11% → 77.77% (+3.7%)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

4% less capital invested

Capital invested by funds: $795M → $762M (-$32.7M)

7% less funds holding

Funds holding: 71 → 66 (-5)

42% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 12

Holders
66
Holders Change
-5
Holders Change %
-7.04%
% of All Funds
1.16%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
7
Increased
33
Reduced
11
Closed
12
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$30.1M
2
BlackRock
BlackRock
New York
+$18.4M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$14M
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$5.04M
5
Goldman Sachs
Goldman Sachs
New York
+$3.88M

Top Sellers

Rank Fund Capital Flow
1
IC
Ikarian Capital
Texas
-$7.61M
2
VA
VR Adviser
New York
-$7.22M
3
MB
MPM BioImpact
Massachusetts
-$7.1M
4
PVI
Pura Vida Investments
New York
-$4.26M
5
EP
Eversept Partners
New York
-$4.22M
Name Holding Trade Value Shares
Change 		Change in
Stake
Goldman Sachs
26
Goldman Sachs
New York
$3.56M +$3.88M +145,148 +1,175%
Citadel Advisors
27
Citadel Advisors
Florida
$2.4M +$80.9K +3,025 +3%
AG
28
Artal Group
Luxembourg
$2.26M – – –
PVI
29
Pura Vida Investments
New York
$1.84M -$4.26M -159,380 -66%
Bank of New York Mellon
30
Bank of New York Mellon
New York
$1.81M +$1.08M +40,537 +102%
Morgan Stanley
31
Morgan Stanley
New York
$1.6M +$119K +4,450 +7%
BC
32
Birchview Capital
Vermont
$1.02M – – –
SSA
33
Schonfeld Strategic Advisors
New York
$809K +$959K +35,858 New
Victory Capital Management
34
Victory Capital Management
Texas
$728K -$7.22K -270 -0.8%
RhumbLine Advisers
35
RhumbLine Advisers
Massachusetts
$700K +$428K +15,998 +106%
MFS
36
Mirabella Financial Services
United Kingdom
$670K +$794K +29,686 New
Swiss National Bank
37
Swiss National Bank
Switzerland
$646K – – –
DFCM
38
Dark Forest Capital Management
Puerto Rico
$573K +$300K +11,237 +79%
California State Teachers Retirement System (CalSTRS)
39
California State Teachers Retirement System (CalSTRS)
California
$557K +$172K +6,420 +35%
State of Wisconsin Investment Board
40
State of Wisconsin Investment Board
Wisconsin
$386K +$54.2K +2,028 +13%
SG Americas Securities
41
SG Americas Securities
New York
$358K +$424K +15,863 New
Deutsche Bank
42
Deutsche Bank
Germany
$343K +$184K +6,882 +83%
JP Morgan Chase
43
JP Morgan Chase
New York
$341K +$188K +7,015 +86%
AllianceBernstein
44
AllianceBernstein
Tennessee
$311K – – –
Manulife (Manufacturers Life Insurance)
45
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$309K +$155K +5,805 +74%
Ensign Peak Advisors
46
Ensign Peak Advisors
Utah
$276K +$193K +7,212 +144%
New York State Common Retirement Fund
47
New York State Common Retirement Fund
New York
$267K +$1.18K +44 +0.4%
MIM
48
MetLife Investment Management
New Jersey
$221K +$99.2K +3,710 +61%
B
49
Bailard
California
$217K +$257K +9,600 New
CS
50
Credit Suisse
Switzerland
$215K +$13.4K +503 +6%
1
2
3 4

CGEM Hedge Fund Activity: Q3 2021 in Review

66 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Cullinan Oncology (CGEM) for Q3 2021, worth a combined $762M — down 4.1% from $795M a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of CGEM and 7 opened new positions — a net loss of 5 holders — while 11 trimmed existing stakes and 33 added.

The largest buyer was Vanguard Group, adding an estimated $30.1M. The largest seller was Ikarian Capital, exiting entirely with an estimated $7.61M sold.

  • 66 institutional investors held Cullinan Oncology (CGEM) as of Q3 2021, down from 71 in Q2 2021.
  • Funds reported $762M of Cullinan Oncology stock for Q3 2021, down 4.1% quarter-over-quarter.
  • 7 funds opened new Cullinan Oncology positions in Q3 2021 and 12 closed out, a net change of -5 holders.
  • The largest Cullinan Oncology buyer in Q3 2021 was Vanguard Group, an estimated $30.1M added.
  • The largest Cullinan Oncology seller in Q3 2021 was Ikarian Capital, an estimated $7.61M sold.

Based on aggregated 13F filings for Q3 2021.